$ALNY 4/A SEC Filings

Filed On	Filing
12 Feb 2020	Form 4/A: Keating Laurie, EVP, Chief Legal Officer Received 3,663 shares by exercise or conversion ($284K)
02 Feb 2015	Form 4/A: Sanofi, 10% owner Bought 196,251 shares ($18.3M)
28 Oct 2014	Form 4/A: Alnylam PHARMACEUTICALS, Inc., 10% owner · Regulus Therapeutics Inc. Sold 109,534 shares ($1.53M) · Sold 1,700 shares ($24.2K) · Sold 1,850 shares ($28.1K)
24 Sep 2013	Form 4/A: Maraganore John, Director Granted 10,000 Stock Option (right to buy)
15 Jun 2010	Form 4/A: Reid Laurence, SVP, Chief Business Officer Granted 175,000 Stock Option (right to buy)
16 Jun 2006	Form 4/A: Barrett Peter, Director Granted 10,000 Stock Option (right to buy)
15 Mar 2005	Form 4/A: Abingworth Management Ltd, 10% owner Received 2,033,668 shares by conversion
10 Mar 2005	Form 4/A: Abingworth Management Ltd, 10% owner Bought 130,520 shares ($783K)
21 Dec 2004	Form 4/A: Polaris Venture Management Co Iii Llc, 10% owner and 7 others Sold 37,000 shares ($250K)
21 Dec 2004	Form 4/A: Polaris Venture Management Co Iii Llc, 10% owner and 7 others Sold 166,500 shares ($1.09M)
07 Jun 2004	Form 4/A: Atlas Venture Fund V Lp, 10% owner and 8 others Bought 356,001 shares ($2.14M) · Bought 88,999 shares ($534K)
07 Jun 2004	Form 4/A: Barrett Peter, Director Bought 95,222 shares ($571K) · Bought 127,278 shares ($764K)

Comments